Virios Therapeutics Announces Third Quarter 2021 Financial Results and Provides Corporate Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall St set to open higher as tech rebounds, Micron earnings eyed
- Brent hits lowest since before start of Iran war on expectations of smoother oil flows via Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- JPMorgan raises S&P 500 target to 7,800, says earnings revision ’unprecedented’
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Virios Therapeutics (VIRI) Tops Q3 EPS by 20c; Reports Cash Position of $19.2M
November 11, 2021 7:07 AM ESTVirios Therapeutics (NASDAQ: VIRI) reported Q3 EPS of ($0.49), $0.20 better than the analyst estimate of ($0.69). Revenue for the quarter came in at $0 , versus $0 reported last year.
For earnings history and earnings-related data on Virios Therapeutics (VIRI) click here.
... More